Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ENVX NYSE:KSS NASDAQ:SAVA NYSEARCA:SPY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeENVXEnovix$13.19+2.5%$10.41$5.27▼$16.49$2.59B2.076.85 million shs13.83 million shsKSSKohl's$15.33-1.1%$15.27$6.04▼$21.39$1.72B1.7110.46 million shs2.68 million shsSAVACassava Sciences$4.64+4.7%$2.69$1.15▼$33.98$224.16M-0.981.81 million shs4.15 million shsSPYSPDR S&P 500 ETF Trust$665.17+0.4%$653.07$481.80▼$673.95$673.67B170.42 million shs81.53 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceENVXEnovix-1.15%+3.62%+58.11%-14.77%+0.47%KSSKohl's-0.29%-2.67%+1.14%+64.66%-19.80%SAVACassava Sciences+8.05%+29.53%+109.95%+114.01%-83.89%SPYSPDR S&P 500 ETF Trust-0.12%-1.03%+0.73%+6.09%+13.34%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeENVXEnovix$13.19+2.5%$10.41$5.27▼$16.49$2.59B2.076.85 million shs13.83 million shsKSSKohl's$15.33-1.1%$15.27$6.04▼$21.39$1.72B1.7110.46 million shs2.68 million shsSAVACassava Sciences$4.64+4.7%$2.69$1.15▼$33.98$224.16M-0.981.81 million shs4.15 million shsSPYSPDR S&P 500 ETF Trust$665.17+0.4%$653.07$481.80▼$673.95$673.67B170.42 million shs81.53 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceENVXEnovix-1.15%+3.62%+58.11%-14.77%+0.47%KSSKohl's-0.29%-2.67%+1.14%+64.66%-19.80%SAVACassava Sciences+8.05%+29.53%+109.95%+114.01%-83.89%SPYSPDR S&P 500 ETF Trust-0.12%-1.03%+0.73%+6.09%+13.34%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceENVXEnovix 2.36Hold$17.0028.89% UpsideKSSKohl's 1.72Reduce$12.75-16.80% DownsideSAVACassava Sciences 1.50Reduce$2.00-56.90% DownsideSPYSPDR S&P 500 ETF Trust 2.83Moderate Buy$665.17N/ACurrent Analyst Ratings BreakdownLatest SPY, ENVX, SAVA, and KSS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/14/2025KSSKohl'sBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral10/8/2025ENVXEnovixWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025KSSKohl'sWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/8/2025SAVACassava SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025ENVXEnovixWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025KSSKohl'sWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025SAVACassava SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/19/2025KSSKohl'sCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$16.00 ➝ $19.009/18/2025KSSKohl'sMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetUnderweight$5.00 ➝ $9.008/28/2025KSSKohl'sCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold8/28/2025KSSKohl'sCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$8.00 ➝ $16.00(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookENVXEnovix$26.60M97.49N/AN/A$1.40 per share9.42KSSKohl's$15.89B0.11$8.07 per share1.90$34.15 per share0.45SAVACassava SciencesN/AN/AN/AN/A$3.03 per shareN/ASPYSPDR S&P 500 ETF TrustN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateENVXEnovix-$222.24M-$0.84N/AN/AN/A-481.35%-73.88%-32.85%11/4/2025 (Estimated)KSSKohl's$109M$1.858.2812.56N/A1.31%4.62%1.27%11/25/2025 (Estimated)SAVACassava Sciences-$24.34M-$2.55N/AN/AN/AN/A-66.16%-53.11%11/6/2025 (Estimated)SPYSPDR S&P 500 ETF TrustN/AN/A25.94∞N/AN/AN/AN/AN/ALatest SPY, ENVX, SAVA, and KSS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/4/2025Q3 2025ENVXEnovix-$0.16N/AN/AN/AN/AN/A9/9/2025Q2 2025ENVXEnovixN/A-$0.13N/AN/AN/A$7.47 million8/27/2025Q2 2026KSSKohl's$0.33$0.56+$0.23$1.35$3.37 billion$3.35 billion8/14/2025Q2 2025SAVACassava SciencesN/A-$0.18N/A-$0.92N/AN/A7/31/2025Q2 2025ENVXEnovix-$0.15-$0.13+$0.02-$0.22$5.48 million$7.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthENVXEnovixN/AN/AN/AN/AN/AKSSKohl's$0.503.26%N/A27.03%N/ASAVACassava SciencesN/AN/AN/AN/AN/ASPYSPDR S&P 500 ETF Trust$7.251.09%N/AN/AN/ALatest SPY, ENVX, SAVA, and KSS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/12/2025KSSKohl'squarterly$0.12503.12%9/10/20259/10/20259/24/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioENVXEnovix0.824.374.11KSSKohl's1.001.360.19SAVACassava SciencesN/A2.432.43SPYSPDR S&P 500 ETF TrustN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipENVXEnovix50.92%KSSKohl's98.04%SAVACassava Sciences38.05%SPYSPDR S&P 500 ETF Trust63.54%Insider OwnershipCompanyInsider OwnershipENVXEnovix14.10%KSSKohl's1.00%SAVACassava Sciences12.20%SPYSPDR S&P 500 ETF TrustN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableENVXEnovix340196.60 million168.88 millionOptionableKSSKohl's87,000112.08 million110.95 millionOptionableSAVACassava Sciences3048.31 million42.41 millionOptionableSPYSPDR S&P 500 ETF TrustN/A1.01 billionN/ANot OptionableSPY, ENVX, SAVA, and KSS HeadlinesRecent News About These CompaniesMarket Close Stock Round-Up October 15, 2025: S&P, NASDAQ See Modest Lifts2 hours ago | ibtimes.comIStrong Bank Earnings Push S&P 500 Higher4 hours ago | wsj.comSPY ETF News, 10/15/2025October 15 at 2:11 PM | tipranks.comThis Insurer Is Today's Worst Stock in the S&P 500. Here's Why.October 15 at 10:35 AM | barrons.comNASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Look to RecoverOctober 15 at 9:20 AM | fxempire.comFNew Prescription for Gains: Behind Q4 Healthcare LeadOctober 15 at 8:03 AM | etftrends.comESPY ETF News, 10/14/2025October 14 at 1:50 PM | tipranks.comNASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Look Soft in PremarketOctober 14 at 8:49 AM | fxempire.comFWorld Markets Watchlist: October 13, 2025October 13 at 6:39 PM | etftrends.comESPY ETF News, 10/13/2025October 13 at 1:50 PM | tipranks.comDisruptive Investing Helps Communications ETF FDCF Consistently OutperformOctober 13 at 1:34 PM | etftrends.comENASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Recover in PremarketOctober 13 at 9:22 AM | fxempire.comFPullback Risks Increase as S&P 500 Approaches Key TrendlineOctober 13 at 8:42 AM | schaeffersresearch.comSPDR S&P 500 ETF Trust Sees Strong Fund InflowsOctober 11, 2025 | tipranks.comThe "Magnificent Seven" or the Entire S&P 500: What's the Better Option for Growth Investors?October 11, 2025 | fool.comS&P 500 Snapshot: Largest Loss in Six MonthsOctober 10, 2025 | etftrends.comEStock Market News October 10: S&P 500 (SPY) Falls 1.59% Before Earnings Kick-OffOctober 10, 2025 | 247wallst.comSPY ETF News, 10/10/2025October 10, 2025 | tipranks.comHere's to a Second $1 Trillion Year for ETFsOctober 10, 2025 | etftrends.comEParty Rally Running Out of FuelOctober 9, 2025 | zacks.comThese Are the 3 Hottest Sectors for Q3 Earnings Growth...October 7, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025NVIDIA Breaks Out to New Highs: What Comes Next?By Thomas Hughes | October 2, 2025These Are the 3 Hottest Sectors for Q3 Earnings GrowthBy Thomas Hughes | October 7, 2025SPY, ENVX, SAVA, and KSS Company DescriptionsEnovix NASDAQ:ENVX$13.19 +0.32 (+2.49%) Closing price 04:00 PM EasternExtended Trading$13.26 +0.07 (+0.49%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.Kohl's NYSE:KSS$15.32 -0.17 (-1.07%) Closing price 03:59 PM EasternExtended Trading$15.55 +0.23 (+1.47%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kohl's Corporation operates as an omnichannel retailer in the United States. It offers branded apparel, footwear, accessories, beauty, and home products through its stores and website. The company provides its products primarily under the brand names of Croft & Barrow, Jumping Beans, SO, Sonoma Goods for Life, and Tek Gear, as well as Food Network, LC Lauren Conrad, Nine West, and Simply Vera Vera Wang. Kohl's Corporation was founded in 1988 and is headquartered in Menomonee Falls, Wisconsin.Cassava Sciences NASDAQ:SAVA$4.64 +0.21 (+4.74%) Closing price 04:00 PM EasternExtended Trading$4.61 -0.03 (-0.65%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.SPDR S&P 500 ETF Trust NYSEARCA:SPY$665.17 +2.94 (+0.44%) Closing price 04:10 PM EasternExtended Trading$665.15 -0.02 (0.00%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SPDR S&P 500 ETF Trust (the Trust) is a unit investment trust. The Trust seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500 Index (the Index). The Trust seeks to achieve this investment objective by holding a portfolio of the common stocks that are included in the Index (the Portfolio), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the Index. The Trust invests in a range of sectors, including pharmaceuticals; oil, gas and consumable fuels; technology hardware storage and peripherals; insurance; information technology (IT) services; healthcare providers and services; semiconductors and semiconductor equipment; hotels, restaurants and leisure, communications equipment; commercial services and supplies; road and rail; real estate management and development; containers and packaging; professional services, and paper and forest products. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability 3 Healthcare Companies Insiders Are Buying Tempus AI Hits $100—Are Shares Due for a Pullback? Vertiv Stock Surges on Strategic CFO Hire and AI Momentum NVIDIA Analysts Lift Targets: What It Means for the Stock Price Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Why Congress Is Buying Intuitive Surgical Ahead of Earnings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
